Research Article
Atrial Arrhythmias in Patients with Severe COVID-19
Table 1
Baseline characteristics of patients with bacterial pneumonia and COVID-19 patients.
| | Variable | Bacterial pneumonia (N = 84) | COVID-19 patients (N = 84) | value |
| | Age (yrs) | 61.60 ± 11.30 | 61.90 ± 13.90 | 0.88 | | Male/female (n) | 37/47 | 44/40 | 0.28 | | Weight (kg) | 68.10 ± 22.60 | 66.70 ± 13.90 | 0.72 | | Hypertension (n) | 30 (35.70) | 34 (40.50) | 0.53 | | Diabetes (n) | 9 (10.70) | 19 (22.60) | 0.04 | | Hyperlipidemia (n) | 2 (2.40) | 2 (2.40) | 1.00 | | CAD (n) | 10 (11.90) | 8 (9.50) | 0.62 | | Thyroid disease (n) | 10 (11.90) | 1 (1.20) | 0.01 | | Cardiomyopathy (n) | 1 (1.20) | 0 | 1.00 | | HF (n) | 8 (9.50) | 5 (6.00) | 0.39 | | Stroke (n) | 4 (4.80) | 9 (10.70) | 0.15 | | COPD (n) | 10 (11.90) | 3 (3.60) | 0.04 | | Lung cancer (n) | 19 (22.60) | 1 (1.20) | <0.01 | | Liver disease (n) | 2 (2.40) | 7 (8.30) | 0.17 | | Kidney disease (n) | 0 | 4 (4.80) | 0.12 | | Fever (n) | 14 (16.70) | 60 (71.40) | <0.01 | | Cough (n) | 66 (78.60) | 42 (50.00) | <0.01 | | Dyspnea (n) | 14 (16.70) | 22 (26.20) | 0.13 | | Myalgia (n) | 0 | 17 (20.20) | <0.01 | | Fatigue (n) | 4 (4.80) | 31 (36.90) | <0.01 | | Headache (n) | 2 (2.40) | 8 (9.50) | 0.05 | | SBP (mm/Hg) | 126 (114, 139) | 130 (120, 139) | 0.21 | | DBP (mm/Hg) | 75 (69, 82) | 80 (73, 87) | <0.01 | | Diarrhea (n) | 0 | 3 (3.60) | 0.25 | | β-Blockers (n) | 7 (8.30) | 18 (21.40) | 0.02 | | ACEI/ARB (n) | 11 (13.10) | 7 (8.30) | 0.32 | | Calcium antagonist (n) | 13 (15.50) | 20 (23.80) | 0.17 | | Diuretics (n) | 6 (7.10) | 7 (8.30) | 0.77 | | Antidiabetes agents (n) | 6 (7.10) | 11 (13.10) | 0.20 | | Nitrates (n) | 3 (3.60) | 4 (4.80) | 1.00 | | Statins (n) | 16 (19.00) | 11 (13.10) | 0.29 | | Antiplatelet agents (n) | 11 (13.10) | 10 (11.90) | 0.82 | | AADs (n) | 0 | 13 (15.50) | <0.01 | | Liver-protecting agents (n) | 8 (9.50) | 11 (13.10) | 0.47 |
|
|
Data are expressed as mean (SD) or median (IQR) for continuous variables and number (%) for categorical variables.
|
